Division of Pulmonary, Critical Care and Sleep Medicine, University of Washington, Seattle, WA.
Sleep Apnea Patient-Centered Outcomes Network.
Sleep. 2018 Aug 1;41(8). doi: 10.1093/sleep/zsy093.
Home sleep apnea testing (HSAT) is increasingly used as an alternative to laboratory-based polysomnography (PSG) for the diagnosis of obstructive sleep apnea. Patient satisfaction with sleep testing performed at home or in the lab has been sparsely assessed, despite its potentially pivotal role in determining patients' acceptance of sleep apnea treatment. We hypothesize that satisfaction in clinical practice may differ from what has been previously reported within the research setting.
We analyzed survey data including responses to questions regarding diagnostic sleep study type and sleep study experience satisfaction from 2563 sleep apnea patients enrolled in the Sleep Apnea Patient-Centered Outcomes Network.
Patients (mean age 57 years; 54% male) who underwent in-lab PSG were more likely to be satisfied with their study experience than patients who had a HSAT (71% vs 60%; p < 0.01). Furthermore, the 38 per cent diminished odds of satisfaction in patients having HSAT (OR: 0.62; 95% CI: 0.49-0.77) persisted after adjustment for potential confounders (OR: 0.41, 95% CI; 0.27-0.63). Greater sleep apnea symptom burden and satisfaction with CPAP therapy were associated with greater study satisfaction. Effect modifications on study types by college degree education and tiredness as a study trigger were detected.
Patients receiving care in the community who underwent PSG reported greater satisfaction with study experience than patients who underwent HSAT in contrast to findings from randomized controlled trials. Our findings, based on data from contemporary "real-world" settings, suggest that assumptions about the generalizability of early reports comparing in-lab PSG to home-based paradigms need to be revisited.
家庭睡眠呼吸暂停测试(HSAT)越来越多地被用作替代实验室多导睡眠图(PSG)来诊断阻塞性睡眠呼吸暂停。尽管患者对睡眠测试的满意度可能对确定其对睡眠呼吸暂停治疗的接受程度具有重要作用,但对于在家中或在实验室进行的睡眠测试的满意度评估却很少。我们假设,在临床实践中的满意度可能与以前在研究环境中报告的情况有所不同。
我们分析了睡眠呼吸暂停患者中心结局网络(Sleep Apnea Patient-Centered Outcomes Network)中 2563 名睡眠呼吸暂停患者的调查数据,包括关于诊断性睡眠研究类型和睡眠研究体验满意度的回答。
接受实验室 PSG 的患者(平均年龄 57 岁;54%为男性)比接受 HSAT 的患者更满意他们的研究体验(71%比 60%;p < 0.01)。此外,HSAT 患者满意度降低的几率为 38%(OR:0.62;95%CI:0.49-0.77),在调整潜在混杂因素后(OR:0.41,95%CI;0.27-0.63)仍然存在。更大的睡眠呼吸暂停症状负担和对 CPAP 治疗的满意度与更大的研究满意度相关。在研究类型上检测到了与大学学历教育和疲劳作为研究触发因素的效果修饰。
与随机对照试验的结果相反,在社区接受治疗的接受 PSG 的患者报告的研究体验满意度高于接受 HSAT 的患者。我们基于当代“真实世界”背景下的数据得出的发现表明,需要重新审视早期报告中关于将实验室 PSG 与家庭模式进行比较的普遍性的假设。